• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human FERM domain-containing protein 8 (FRMD8)

ACP10397

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP10397 Target NameFRMD8
Target SynonymsFERM domain containing 8; FERM domain containing protein 8; FERM domain-containing protein 8; FKSG44; FLJ32216; FLJ90369; Frmd8; FRMD8_HUMAN; MGC31785FormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Expression Range1-464
Protein LengthFull length proteinPurity>85% (SDS-PAGE)
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ9BZ67
Background Information
  • Uniprot Id

    Q9BZ67

  • Target Species

    Human

  • Target Name

    FRMD8

  • Target Full Name

    FERM domain-containing protein 8

  • Target Function

    Promotes the cell surface stability of iRhom1/RHBDF1 and iRhom2/RHBDF2 and prevents their degradation via the endolysosomal pathway. By acting on iRhoms, involved in ADAM17-mediated shedding of TNF, amphiregulin/AREG, HBEGF and TGFA from the cell surface. Negatively regulates Wnt signaling, possibly by antagonizing the recruitment of AXIN1 to LRP6.

  • Target Subcellular Location

    Cytoplasm, cytosol. Cell membrane.

  • Target Tissue Specificity

    Widely expressed, with high expression in heart and spleen.

  • Target Synonyms

    FERM domain containing 8; FERM domain containing protein 8; FERM domain-containing protein 8; FKSG44; FLJ32216; FLJ90369; Frmd8; FRMD8_HUMAN; MGC31785

Inquire Recombinant Human FERM domain-containing protein 8 (FRMD8) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification